231 related articles for article (PubMed ID: 26497523)
1. Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII.
Sutton BJ; Davies AM
Immunol Rev; 2015 Nov; 268(1):222-35. PubMed ID: 26497523
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcεRI.
Dhaliwal B; Yuan D; Pang MO; Henry AJ; Cain K; Oxbrow A; Fabiane SM; Beavil AJ; McDonnell JM; Gould HJ; Sutton BJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12686-91. PubMed ID: 22802656
[TBL] [Abstract][Full Text] [Related]
3. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
[TBL] [Abstract][Full Text] [Related]
4. Ca2+-dependent structural changes in the B-cell receptor CD23 increase its affinity for human immunoglobulin E.
Yuan D; Keeble AH; Hibbert RG; Fabiane S; Gould HJ; McDonnell JM; Beavil AJ; Sutton BJ; Dhaliwal B
J Biol Chem; 2013 Jul; 288(30):21667-77. PubMed ID: 23775083
[TBL] [Abstract][Full Text] [Related]
5. Mapping of the CD23 binding site on immunoglobulin E (IgE) and allosteric control of the IgE-Fc epsilonRI interaction.
Borthakur S; Hibbert RG; Pang MO; Yahya N; Bax HJ; Kao MW; Cooper AM; Beavil AJ; Sutton BJ; Gould HJ; McDonnell JM
J Biol Chem; 2012 Sep; 287(37):31457-61. PubMed ID: 22815482
[TBL] [Abstract][Full Text] [Related]
6. Thermal sensitivity and flexibility of the Cε3 domains in immunoglobulin E.
Doré KA; Davies AM; Drinkwater N; Beavil AJ; McDonnell JM; Sutton BJ
Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1336-1347. PubMed ID: 28844738
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody.
Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM
Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035
[TBL] [Abstract][Full Text] [Related]
8. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
9. Structural and Physical Basis for Anti-IgE Therapy.
Wright JD; Chu HM; Huang CH; Ma C; Chang TW; Lim C
Sci Rep; 2015 Jun; 5():11581. PubMed ID: 26113483
[TBL] [Abstract][Full Text] [Related]
10. The intrinsic flexibility of IgE and its role in binding FcepsilonRI.
Harwood NE; McDonnell JM
Biomed Pharmacother; 2007 Jan; 61(1):61-7. PubMed ID: 17188833
[TBL] [Abstract][Full Text] [Related]
11. Conformational plasticity at the IgE-binding site of the B-cell receptor CD23.
Dhaliwal B; Pang MO; Yuan D; Yahya N; Fabiane SM; McDonnell JM; Gould HJ; Beavil AJ; Sutton BJ
Mol Immunol; 2013 Dec; 56(4):693-7. PubMed ID: 23933509
[TBL] [Abstract][Full Text] [Related]
12. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS
Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871
[TBL] [Abstract][Full Text] [Related]
13. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.
Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ
J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838
[TBL] [Abstract][Full Text] [Related]
14. Structure of the human IgE-Fc C epsilon 3-C epsilon 4 reveals conformational flexibility in the antibody effector domains.
Wurzburg BA; Garman SC; Jardetzky TS
Immunity; 2000 Sep; 13(3):375-85. PubMed ID: 11021535
[TBL] [Abstract][Full Text] [Related]
15. A fluorescent biosensor reveals conformational changes in human immunoglobulin E Fc: implications for mechanisms of receptor binding, inhibition, and allergen recognition.
Hunt J; Keeble AH; Dale RE; Corbett MK; Beavil RL; Levitt J; Swann MJ; Suhling K; Ameer-Beg S; Sutton BJ; Beavil AJ
J Biol Chem; 2012 May; 287(21):17459-17470. PubMed ID: 22442150
[TBL] [Abstract][Full Text] [Related]
16. A range of Cℇ3-Cℇ4 interdomain angles in IgE Fc accommodate binding to its receptor CD23.
Dhaliwal B; Pang MO; Yuan D; Beavil AJ; Sutton BJ
Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):305-9. PubMed ID: 24598915
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the interactions between human IgE and its high affinity receptor FcepsilonRI.
Wurzburg BA; Jardetzky TS
Mol Immunol; 2002 May; 38(14):1063-72. PubMed ID: 11955598
[TBL] [Abstract][Full Text] [Related]
18. The structure of human CD23 and its interactions with IgE and CD21.
Hibbert RG; Teriete P; Grundy GJ; Beavil RL; Reljic R; Holers VM; Hannan JP; Sutton BJ; Gould HJ; McDonnell JM
J Exp Med; 2005 Sep; 202(6):751-60. PubMed ID: 16172256
[TBL] [Abstract][Full Text] [Related]
19. Current progress in the understanding of IgE-FcepsilonRI interaction.
Vangelista L
Int Arch Allergy Immunol; 2003 Aug; 131(4):222-33. PubMed ID: 12915765
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI.
MacGlashan D; Lichtenstein LM; McKenzie-White J; Chichester K; Henry AJ; Sutton BJ; Gould HJ
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):492-8. PubMed ID: 10452777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
